• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

服用阿卡波糖后会出现胃排空延迟,这是其降血糖作用的另一种机制。

Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect.

作者信息

Ranganath L, Norris F, Morgan L, Wright J, Marks V

机构信息

Epsom General Hospital, Surrey, UK.

出版信息

Diabet Med. 1998 Feb;15(2):120-4. doi: 10.1002/(SICI)1096-9136(199802)15:2<120::AID-DIA529>3.0.CO;2-I.

DOI:10.1002/(SICI)1096-9136(199802)15:2<120::AID-DIA529>3.0.CO;2-I
PMID:9507911
Abstract

The therapeutic effect of acarbose is generally attributed to inhibition of amylase and brush border glucosidases and consequent impaired digestion and absorption of carbohydrates. We have investigated the possibility that acarbose may also influence the rate of gastric emptying by comparing plasma glucose and gastrointestinal hormone responses to an oral sucrose load with and without acarbose in 11 healthy subjects. Gastric emptying was assessed indirectly by measuring circulating paracetamol concentrations following administration of paracetamol along with the sucrose load. Peak plasma glucose, insulin, and glucose-dependent insulinotropic polypeptide (GIP) responses were reduced when sucrose was given with acarbose. There was a significant reduction in post-sucrose paracetamol levels with acarbose suggestive of a significant delay in gastric emptying. The failure of acarbose to induce change in circulating paracetamol concentrations until after 60 min is indicative of a delay in gastric emptying rather than an osmotic malabsorption. The exaggerated and sustained release of glucagon-like peptide-1 (7-36)amide (GLP-1) seen when sucrose was given with acarbose may play a part in the inhibition of gastric emptying. This study indicates that a significant delay in gastric emptying may be an added mechanism contributing to the therapeutic effect of acarbose.

摘要

阿卡波糖的治疗作用通常归因于对淀粉酶和刷状缘糖苷酶的抑制,以及随之而来的碳水化合物消化和吸收受损。我们通过比较11名健康受试者在服用和未服用阿卡波糖时口服蔗糖负荷后的血糖和胃肠激素反应,研究了阿卡波糖是否也可能影响胃排空速率。通过在给予对乙酰氨基酚的同时给予蔗糖负荷后测量循环中的对乙酰氨基酚浓度,间接评估胃排空情况。当蔗糖与阿卡波糖一起服用时,血浆葡萄糖、胰岛素和葡萄糖依赖性促胰岛素多肽(GIP)的峰值反应降低。服用阿卡波糖后,蔗糖后对乙酰氨基酚水平显著降低,提示胃排空明显延迟。阿卡波糖直到60分钟后才引起循环中对乙酰氨基酚浓度的变化,这表明是胃排空延迟而非渗透性吸收不良。当蔗糖与阿卡波糖一起服用时,观察到胰高血糖素样肽-1(7-36)酰胺(GLP-1)过度且持续释放,这可能在抑制胃排空中起作用。这项研究表明,胃排空明显延迟可能是阿卡波糖治疗作用的另一个机制。

相似文献

1
Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect.服用阿卡波糖后会出现胃排空延迟,这是其降血糖作用的另一种机制。
Diabet Med. 1998 Feb;15(2):120-4. doi: 10.1002/(SICI)1096-9136(199802)15:2<120::AID-DIA529>3.0.CO;2-I.
2
alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.α-葡萄糖苷酶抑制作用(阿卡波糖)未能增强2型糖尿病患者胰高血糖素样肽1(7-36酰胺)的分泌,也未能延迟胃排空。
Diabet Med. 2005 Apr;22(4):470-6. doi: 10.1111/j.1464-5491.2005.01451.x.
3
Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.阿卡波糖对胃排空的抑制作用与胰高血糖素样肽-1反应相关,并伴有胆囊收缩素的释放。
Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G752-63. doi: 10.1152/ajpgi.2001.281.3.G752.
4
Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.2型糖尿病患者口服蔗糖后,由于α-葡萄糖苷酶抑制(阿卡波糖)导致胰高血糖素样肽1(7-36酰胺)分泌延长且增强。
Diabet Med. 1998 Jun;15(6):485-91. doi: 10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y.
5
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.红霉素可拮抗胰高血糖素样肽1引起的胃排空减速,并在健康受试者中揭示其促胰岛素分泌作用。
Diabetes. 2005 Jul;54(7):2212-8. doi: 10.2337/diabetes.54.7.2212.
6
Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1).胰高血糖素对碳水化合物介导的葡萄糖依赖性促胰岛素多肽(GIP)和胰高血糖素样肽-1(7-36酰胺)(GLP-1)分泌的影响。
Diabetes Metab Res Rev. 1999 Nov-Dec;15(6):390-4. doi: 10.1002/(sici)1520-7560(199911/12)15:6<390::aid-dmrr67>3.0.co;2-w.
7
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.在健康人体中,胰高血糖素样肽1对胃排空的抑制作用超过其促胰岛素分泌作用。
Am J Physiol. 1997 Nov;273(5):E981-8. doi: 10.1152/ajpendo.1997.273.5.E981.
8
Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly.阿卡波糖可减弱老年人对蔗糖的降压反应并减缓胃排空。
Am J Med. 2005 Nov;118(11):1289. doi: 10.1016/j.amjmed.2005.05.019.
9
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.液体试验餐后的胃排空、葡萄糖反应及胰岛素分泌:外源性胰高血糖素样肽-1(GLP-1)-(7-36)酰胺对2型(非胰岛素依赖型)糖尿病患者的影响
J Clin Endocrinol Metab. 1996 Jan;81(1):327-32. doi: 10.1210/jcem.81.1.8550773.
10
Gastric emptying and release of incretin hormones after glucose ingestion in humans.人体摄入葡萄糖后胃排空及肠促胰岛素激素的释放
J Clin Invest. 1996 Jan 1;97(1):92-103. doi: 10.1172/JCI118411.

引用本文的文献

1
Maltitol: Analytical Determination Methods, Applications in the Food Industry, Metabolism and Health Impacts.麦芽糖醇:分析测定方法、食品工业中的应用、代谢及健康影响。
Int J Environ Res Public Health. 2020 Jul 20;17(14):5227. doi: 10.3390/ijerph17145227.
2
Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity.奥利司他与阿卡波糖新型组合对肥胖者耐受性、食欲及糖代谢的影响
Obes Sci Pract. 2020 Feb 7;6(3):313-323. doi: 10.1002/osp4.405. eCollection 2020 Jun.
3
Erythritol reduces small intestinal glucose absorption, increases muscle glucose uptake, improves glucose metabolic enzymes activities and increases expression of Glut-4 and IRS-1 in type 2 diabetic rats.
赤藓糖醇可减少小肠葡萄糖吸收,增加肌肉葡萄糖摄取,改善葡萄糖代谢酶活性,并增加 2 型糖尿病大鼠的 Glut-4 和 IRS-1 的表达。
Eur J Nutr. 2018 Oct;57(7):2431-2444. doi: 10.1007/s00394-017-1516-x. Epub 2017 Aug 2.
4
Incretin secretion in humans is under the influence of cannabinoid receptors.人体内的肠促胰岛素分泌受大麻素受体的影响。
Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E359-E366. doi: 10.1152/ajpendo.00080.2017. Epub 2017 Jun 27.
5
The α-glucosidase inhibitor voglibose stimulates delayed gastric emptying in healthy subjects: a crossover study with a C breath test.α-葡萄糖苷酶抑制剂伏格列波糖可刺激健康受试者胃排空延迟:一项采用碳-13呼气试验的交叉研究。
J Clin Biochem Nutr. 2017 May;60(3):216-218. doi: 10.3164/jcbn.16-100. Epub 2017 Apr 20.
6
Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal.单剂量阿卡波糖可降低中国新诊断2型糖尿病患者混合餐后的葡萄糖依赖性促胰岛素多肽和胰高血糖素水平。
BMC Endocr Disord. 2016 Sep 29;16(1):55. doi: 10.1186/s12902-016-0133-7.
7
Myo-inositol inhibits intestinal glucose absorption and promotes muscle glucose uptake: a dual approach study.肌醇抑制肠道葡萄糖吸收并促进肌肉葡萄糖摄取:一项双途径研究。
J Physiol Biochem. 2016 Dec;72(4):791-801. doi: 10.1007/s13105-016-0517-1. Epub 2016 Sep 6.
8
Pleiotropic effects of sitagliptin versus voglibose in patients with type 2 diabetes inadequately controlled via diet and/or a single oral antihyperglycemic agent: a multicenter, randomized trial.西格列汀与伏格列波糖在饮食和/或单种口服抗高血糖药物控制不佳的 2 型糖尿病患者中的多效性作用:一项多中心、随机试验。
BMJ Open Diabetes Res Care. 2016 Apr 19;4(1):e000190. doi: 10.1136/bmjdrc-2015-000190. eCollection 2016.
9
Postprandial effects of a polyphenolic grape extract (PGE) supplement on appetite and food intake: a randomised dose-comparison trial.一种多酚类葡萄提取物(PGE)补充剂对食欲和食物摄入量的餐后影响:一项随机剂量比较试验。
Nutr J. 2015 Sep 14;14:96. doi: 10.1186/s12937-015-0085-1.
10
Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study.米格列醇、阿卡波糖和西他列汀对2型糖尿病患者血浆胰岛素和肠肽的影响:一项交叉研究。
Diabetes Ther. 2015 Jun;6(2):187-96. doi: 10.1007/s13300-015-0113-3. Epub 2015 Jun 9.